1 min listen
ADVENT-HF trial
FromTalking Sleep
ratings:
Length:
37 minutes
Released:
May 3, 2024
Format:
Podcast episode
Description
The world of sleep medicine has had several large recent disruptions with COVID-19 and the Philips Respironics recall. These haven’t been the only ones. If we look back almost a decade, sleep medicine was disrupted by the SERVE-HF results and field safety notice for ResMed ASV devices. Another trial was conducted around the same time as SERVE-HF but utilized Philips ASV devices. Those results have now been published and provide some insight into the use of peak-flow-triggered ASV for those with an ejection fraction of 45% or below. Dr. Douglas Bradley is here to share his results and to offer his thoughts on the use of ASV.
Released:
May 3, 2024
Format:
Podcast episode
Titles in the series (92)
Talking Sleep Trailer: The American Academy of Sleep Medicine (AASM) is introducing its Talking Sleep podcast with the host, Dr. Seema Khosla. The episodes will feature conversations with clinicians, researchers, sleep team members and other health care experts working to ... by Talking Sleep